Zhonghong Medical announced that the company plans to sell no more than 1,4362 million repurchased shares through centralized bidding, accounting for 0.33% of the total share capital. The sale period is from October 23, 2026 to April 22, 2027. The sale price is determined based on the secondary market price at the time of sale, and the proceeds will be used to supplement the company's working capital.

Zhitongcaijing · 2d ago
Zhonghong Medical announced that the company plans to sell no more than 1,4362 million repurchased shares through centralized bidding, accounting for 0.33% of the total share capital. The sale period is from October 23, 2026 to April 22, 2027. The sale price is determined based on the secondary market price at the time of sale, and the proceeds will be used to supplement the company's working capital.